Wu Hsiung Chen
Direktor/Vorstandsmitglied bei Tai Hsin Venture Capital Co., Ltd. /Taiwan/
Profil
Wu Hsiung Chen has founded CytoPharm, Inc. in 2003.
He is currently a Director at Tai Hsin Venture Capital Co., Ltd.
Dr. Chen's former positions include Chairman at Ho Tung Chemical Corp., Chairman at Chia-Ho Co., Ltd., and Director at Merit Biotech, Inc. He has also briefly held the position of Chairman at Vita Genomics, Inc. in 2011.
Dr. Chen has a graduate degree from West Virginia University and an undergraduate degree from National Taiwan University.
Aktive Positionen von Wu Hsiung Chen
| Unternehmen | Position | Beginn |
|---|---|---|
| Tai Hsin Venture Capital Co., Ltd. /Taiwan/ | Direktor/Vorstandsmitglied | 22.09.2011 |
Ehemalige bekannte Positionen von Wu Hsiung Chen
| Unternehmen | Position | Ende |
|---|---|---|
| MERIT BIOTECH INC | Direktor/Vorstandsmitglied | - |
| Chia-Ho Co., Ltd. | Vorsitzender | - |
| HO TUNG CHEMICAL CORP. | Vorsitzender | - |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Vorsitzender | 26.09.2011 |
CytoPharm, Inc.
 CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Gründer | - |
Ausbildung von Wu Hsiung Chen
| National Taiwan University | Undergraduate Degree |
| West Virginia University | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| HO TUNG CHEMICAL CORP. | Process Industries |
| MERIT BIOTECH INC | Health Technology |
| Private Unternehmen | 4 |
|---|---|
CytoPharm, Inc.
CytoPharm, Inc. Pharmaceuticals: MajorHealth Technology CytoPharm, Inc. engages in the biopharmaceutical industry. The company specializes in protein drug development. It focuses on producing human natural cytokines such as interferon, interleukin and chemokine as modulators of human immune system. The products can be utilized in single or cocktail treatment model for chronic virus hepatitis, various oncology diseases, virus infection and autoimmune diseases. The company was founded on February 12, 2003 and is headquartered in Taipei, Taiwan. | Health Technology |
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
| Chia-Ho Co., Ltd. | |
| Tai Hsin Venture Capital Co., Ltd. /Taiwan/ |
